Endothelial DLC1 is dispensable for liver and kidney function in mice

Ying Tan, Su Hao Lo

Research output: Contribution to journalArticlepeer-review


DLC1 is a focal adhesion molecule that regulates cell polarity, proliferation, migration, and survival. DLC1 functions as a tumor suppressor and its expression is often down-regulated in various malignant neoplasms of epithelial origin. Recent studies have suggested that lack of DLC1 in endothelial cells may contribute to the development of angiosarcoma, and that DLC1 mutations have been identified in patients with nephrotic syndrome, a disease mainly due to leaky glomerular filtration barriers. To demonstrate whether lack of endothelial DLC1 induces angiosarcoma and/or damages glomerular capillaries leading to nephrotic syndrome, we have extended our analyses on endothelial cell-specific DLC1 knockout mice with focuses on their liver and kidney function. Mice were monitored up to 24 months of age. However, no histological or clinical difference was found between DLC1 knockout and wild type mice, indicating that lack of endothelial DLC1 alone does not compromise kidney and liver function in mice.

Original languageEnglish (US)
JournalGenes and Diseases
StateAccepted/In press - 2020


  • Angiosarcoma
  • DLC1
  • Focal adhesion
  • Nephrotic syndrome
  • Tumor suppressor

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics(clinical)
  • Cell Biology


Dive into the research topics of 'Endothelial DLC1 is dispensable for liver and kidney function in mice'. Together they form a unique fingerprint.

Cite this